Development of a new vaccine for the prevention of Lassa fever.
BACKGROUND: Recent importation of Lassa fever into Germany, the Netherlands, the United Kingdom, and the United States by travelers on commercial airlines from Africa underscores the public health challenge of emerging viruses. Currently, there are no licensed vaccines for Lassa fever, and no experi...
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2005-06-01
|
| Series: | PLoS Medicine |
| Online Access: | http://dx.doi.org/10.1371/journal.pmed.0020183 |